Explore how an innovative medicine moves from approval to patient access.
Selected market
Switzerland
Swissmedic authorisation is followed by a BAG decision for ambulatory inclusion in the Spezialitätenliste, using WZW, therapeutic comparison and international price comparison. Inpatient and individual Article 71 routes remain separate.
Swissmedic
applicant / BAG
BAG / EAK
BAG
BAG
8 decision nodes14 cited sources
For education only — not regulatory, pricing or legal advice.
